(Q47937614)

6 February 2018

title

Preclinical studies with prothymosin alpha1 on mononuclear cells from tumor patients (English)

1 reference

6 February 2018

author name string

Eckert K

1

1 reference

6 February 2018

Grünberg E

2

1 reference

6 February 2018

Garbin F

3

1 reference

6 February 2018

Maurer HR

4

1 reference

6 February 2018

publication date

1 September 1997

1 reference

6 February 2018

International Journal of Immunopharmacology

published in

1 reference

6 February 2018

volume

19

1 reference

6 February 2018

issue

9-10

1 reference

6 February 2018

page(s)

493-500

1 reference

6 February 2018

Depressed levels of granular lymphocytes with natural killer (NK) cell function in 247 cancer patients

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900079-9

7 January 2021

Prothymosin alpha restores depressed allogeneic cell-mediated lympholysis and natural-killer-cell activity in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900079-9

7 January 2021

Prothymosin alpha 1 modulates lymphokine-activated killer cell activity and IL-2 production by peripheral blood lymphocytes from melanoma patients in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900079-9

7 January 2021

Prothymosin alpha: a biologically active protein with random coil conformation.

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900079-9

7 January 2021

Prothymosin alpha1 effects on IL-2-induced expression of LFA-1 on lymphocytes and their adhesion to human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900079-9

7 January 2021

Promotion of murine antitumor activity by prothymosin alpha treatment: I. Induction of tumoricidal peritoneal cells producing high levels of tumour necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900079-9

7 January 2021

Monocyte dysfunction in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0192-0561%2897%2900079-9

7 January 2021

10.1016/S0192-0561(97)00079-9

Identifiers

DOI

1 reference

6 February 2018

release_klpru6fdgre4lfwe6zyxzpqkem

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/klpru6fdgre4lfwe6zyxzpqkem

24 November 2022

mapped directly with Wikidata item

1 reference

6 February 2018